BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35530147)

  • 21. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-metabolizing enzymes: role in drug resistance in cancer.
    Kaur G; Gupta SK; Singh P; Ali V; Kumar V; Verma M
    Clin Transl Oncol; 2020 Oct; 22(10):1667-1680. PubMed ID: 32170639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.
    Tao G; Huang J; Moorthy B; Wang C; Hu M; Gao S; Ghose R
    Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1109-1124. PubMed ID: 32841068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.
    Mallick P; Taneja G; Moorthy B; Ghose R
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):605-616. PubMed ID: 28537216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
    Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
    J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
    Feng S; Li A; Zheng YC; Liu HM
    Curr Drug Metab; 2020; 21(1):67-76. PubMed ID: 31902352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
    Hattinger CM; Serra M
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug disposition in pathophysiological conditions.
    Gandhi A; Moorthy B; Ghose R
    Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.
    Speer JE; Wang Y; Fallon JK; Smith PC; Allbritton NL
    J Biol Eng; 2019; 13():82. PubMed ID: 31709009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small interfering RNA in drug metabolism and transport.
    Yu AM
    Curr Drug Metab; 2007 Oct; 8(7):700-8. PubMed ID: 17979658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology of PXR: role in drug-hormone interactions.
    Wang J; Dai S; Guo Y; Xie W; Zhai Y
    EXCLI J; 2014; 13():728-39. PubMed ID: 26417296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
    Jackson KD; Achour B; Lee J; Geffert RM; Beers JL; Latham BD
    Drug Metab Dispos; 2023 Oct; 51(10):1238-1253. PubMed ID: 37419681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients.
    de Waal T; Handin N; Brouwers J; Miserez M; Hoffman I; Rayyan M; Artursson P; Augustijns P
    Int J Pharm; 2024 Apr; 654():123962. PubMed ID: 38432450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiles of drug-metabolizing enzymes (DMEs) in rat liver during pregnancy and lactation.
    He XJ; Yamauchi H; Suzuki K; Ueno M; Nakayama H; Doi K
    Exp Mol Pathol; 2007 Dec; 83(3):428-34. PubMed ID: 16824515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenges of dealing with promiscuous drug-metabolizing enzymes, receptors and transporters.
    Ma Q; Lu AY
    Curr Drug Metab; 2008 Jun; 9(5):374-83. PubMed ID: 18537574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
    Zeng Z; Zheng W; Hou P
    Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout mice.
    Zheng H; Wang L; Zeng S; Chen J; Wang H; Yu J; Gong X; Jiang H; Yang X; Qi X; Wang Y; Lu L; Hu M; Zhu L; Liu Z
    Biopharm Drug Dispos; 2018 Jul; 39(7):344-353. PubMed ID: 30016542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and convenient biotransformation procedure for human drug metabolizing enzymes using permeabilized fission yeast cells.
    Sharma S; Durairaj P; Bureik M
    Anal Biochem; 2020 Oct; 607():113704. PubMed ID: 32697953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.